|
1
|
Gill S, Thomas RR and Goldberg RM: Review
article: colorectal cancer chemotherapy. Aliment Pharmacol Ther.
18:683–692. 2003. View Article : Google Scholar
|
|
2
|
Aggarwal S and Chu E: Current therapies
for advanced colorectal cancer. Oncology. 19:589–595.
2005.PubMed/NCBI
|
|
3
|
Caldas C and Brenton JD: Sizing up miRNAs
as cancer genes. Nat Med. 11:712–714. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar
|
|
5
|
Jovanovic M and Hengartner MO: miRNAs and
apoptosis: RNAs to die for. Oncogene. 25:6176–6187. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mott JL: MicroRNAs involved in tumor
suppressor and oncogene pathways: implications for hepatobiliary
neoplasia. Hepatology. 50:630–637. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek
SH and Kim VN: MicroRNA genes are transcribed by RNA polymerase II.
EMBO J. 23:4051–4060. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee Y, Ahn C, Han J, et al: The nuclear
RNase III Drosha initiates microRNA processing. Nature.
6956:415–419. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lund E, Güttinger S, Calado A, Dahlberg JE
and Kutay U: Nuclear export of microRNA precursors. Science.
5654:95–98. 2004. View Article : Google Scholar
|
|
10
|
Yi R, Qin Y, Macara IG and Cullen BR:
Exportin-5 mediates the nuclear export of pre-microRNAs and short
hairpin RNAs. Genes Dev. 17:3011–3016. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hutvágner G, McLachlan J, Pasquinelli AE,
Bálint E, Tuschl T and Zamore PD: A cellular function for the
RNA-interference enzyme Dicer in the maturation of the let-7 small
temporal RNA. Science. 5531:834–838. 2001.PubMed/NCBI
|
|
12
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cullen BR: Transcription and processing of
human microRNA precursors. Mol Cell. 16:861–865. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Carmell MA and Hannon GJ: RNase III
enzymes and the initiation of gene silencing. Nat Struct Mol Biol.
11:214–218. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cummins JM, He Y, Leary RJ, et al: The
colorectal microRNAome. Proc Natl Acad Sci USA. 103:3687–3692.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ambros V, Bartel B, Bartel DP, et al: A
uniform system for microRNA annotation. RNA. 9:277–279. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Karube Y, Tanaka H, Osada H, et al:
Reduced expression of Dicer associated with poor prognosis in lung
cancer patients. Cancer Sci. 96:111–115. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Merritt WM, Lin YG, Han LY, et al: Dicer,
Drosha, and outcomes in patients with ovarian cancer. N Engl J Med.
359:2641–2650. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chiosea S, Jelezcova E, Chandran U,
Acquafondata M, McHale T, Sobol RW and Dhir R: Up-regulation of
dicer, a component of the MicroRNA machinery, in prostate
adenocarcinoma. Am J Pathol. 169:1812–1820. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chiosea S, Jelezcova E, Chandran U, Luo J,
Mantha G, Sobol RW and Dacic S: Overexpression of Dicer in
precursor lesions of lung adenocarcinoma. Cancer Res. 67:2345–2350.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Grelier G, Voirin N, Ay AS, et al:
Prognostic value of Dicer expression in human breast cancers and
association with the mesenchymal phenotype. Br J Cancer.
101:673–683. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stratmann J, Wang CJ, Gnosa S, Wallin A,
Hinselwood D, Sun XF and Zhang H: Dicer and miRNA in relation to
clinicopathological variables in colorectal cancer patients. BMC
Cancer. 11:3452011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Faggad A, Kasajima A, Weichert W,
Stenzinger A, Elwali NE, Dietel M and Denkert C: Down-regulation of
the microRNA processing enzyme Dicer is a prognostic factor in
human colorectal cancer. Histopathology. 20: View Article : Google Scholar : 2012.PubMed/NCBI
|
|
24
|
Faber C, Horst D, Hlubek F and Kirchner T:
Overexpression of Dicer predicts poor survival in colorectal
cancer. Eur J Cancer. 47:1414–1419. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wiemer EA: The role of microRNAs in caner:
no small matter. Eur J Cancer. 43:1529–1544. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nelson P, Kiriakidou M, Sharma A,
Maniataki E and Mourelatos Z: The microRNA world: small is mighty.
Trends Biochem Sci. 28:534–540. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Calin GA and Croce CM: MicroRNA-cancer
connection: the beginning of a new tale. Cancer Res. 66:7390–7394.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zheng ZH, Sun XJ, Fu WN, Guan Y, Gao F,
Wang Y and Sun KL: Decreased expression of DICER1 in gastric
cancer. Chin Med J. 120:2099–2104. 2007.PubMed/NCBI
|
|
29
|
Pampalakis G, Diamandis EP, Katsaros D and
Sotiropoulou G: Down-regulation of dicer expression in ovarian
cancer tissues. Clin Biochem. 43:324–327. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Papachristou DJ, Korpetinou A,
Giannopoulou E, et al: Expression of the ribonucleases Drosha,
Dicer, and Ago2 in colorectal carcinomas. Virchows Arch.
459:431–440. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Flavin RJ, Smyth PC, Finn SP, et al:
Altered eIF6 and Dicer expression is associated with
clinicopathological features in ovarian serous carcinoma patients.
Mod Pathol. 21:676–684. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Martin MG, Payton JE and Link DC: Dicer
and outcomes in patients with acute myeloid leukemia (AML). Leuk.
Res. 33:e1272009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guo X, Liao Q, Chen P, et al: The
microRNA-processing enzymes: Drosha and Dicer can predict prognosis
of nasoparyngeal carcinoma. J Cancer Res Clin Oncol. 138:49–56.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhu DX, Fan L, Lu RN, et al:
Downregulation Dicer expression predicts poor prognosis in chronic
lymphocytic leukemia. Cancer Sci. 103:875–881. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sarasquete M, Gutierrez NC,
Misiewicz-Krzeminska I, et al: Upregulation of Dicer is more
frequent in monoclonal gammopathies of undetermined significance
than in multiple myeloma patients and is associated with longer
survival in symptomatic myeloma patients. Haematologica.
96:468–471. 2011. View Article : Google Scholar
|
|
36
|
Faggad A, Budczites J, Tchemitsa O, et al:
Prognostic significance of Dicer expression in ovarian cancer-link
to global microRNA changes and oestrogen receptor expression. J
Pathol. 220:382–391. 2010.PubMed/NCBI
|
